WHO Centre for Metabolic Bone Diseases, University of Sheffield, UK, GB
J. A. Kanis
Division of Clinical Epidemiology, University of California at San Francisco, USA, GB
D. Black
MRC Environmental Epidemiology Unit, University of Southampton, UK, GB
C. Cooper
INSERM, Paris, France, FR
P. Dargent
USDA Human Research Center, Tufts University, Boston, USA (President, NOF), US
B. Dawson-Hughes
Institute for Public Health, Erasmus MC, Rotterdam, The Netherlands, NL
C. De Laet
INSERM Research Unit, Hôpital Edouard Herriot, Lyon, France (President, IOF), FR
P. Delmas
Garvan Institute of Medical Research, St Vincent”s Hospital, Australia, AU
J. Eisman
Department of Orthopaedics, Malmö General Hospital, Sweden, SE
O. Johnell
Dept Economics, Stockholm School of Economics, Sweden, SE
B. Jonsson
Section of Clinical Epidemiology, Mayo Clinic, Rochester, USA, US
L. Melton
Consulting Statistician, Gothenburg, Sweden, SE
A. Oden
Department of Endocrinology, Leiden University Medical Center, The Netherlands, NL
S. Papapoulos
Ziekenhuis Dijkzigt, Rotterdam, The Netherlands, NL
H. Pols
Division of Bone Diseases, University Hospital, Geneva, Switzerland, CH
R. Rizzoli
ARC Epidemiology Research Unit, University of Manchester, UK;, GB
A. Silman
Division of Bone Metabolism, The Montreal General Hospital, Canada, CA
A. Tenenhouse
, on behalf of the International Osteoporosis Foundation and the National Osteoporosis Foundation, USA
